Kymera Therapeutics Inc (KYMR NASDAQ) stock market data APIs
$66.1704
0.26(0.4%)
as of December 4, 2025
Try our APIs with
free plan!
Kymera Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa and atopic dermatitis. The company also develops STAT6, a type 2 inflammation in allergic and atopic diseases; and TYK2 to treat autoimmune and inflammatory diseases. The company has a strategic alliance with Sanofi S.A. for the development of drug candidates targeting IRAK4 outside of the oncology and immuno-oncology fields. Kymera Therapeutics, Inc. was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
Prev. Close
66.1704
Open
66.4351
High
69.1369
Low
65.3616
52 wk Range
19.445-68.8
Market Cap
4 765 M
Shares Outstanding
71 949 K
Revenue
43 735 K
EPS
-0.94
Beta
2.296
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Kymera Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Kymera Therapeutics Inc data using free add-ons & libraries
Get Kymera Therapeutics Inc Fundamental Data
Kymera Therapeutics Inc Fundamental data includes:
- Net Revenue: 43 735 K
- EBITDA: -321 535 008
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-29
- EPS/Forecast: -0.8613
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Kymera Therapeutics Inc News
New
Kymera Therapeutics (KYMR) Up 10.2% Since Last Earnings Report: Can It Continue?
It has been about a month since the last earnings report for Kymera Therapeutics, Inc. (KYMR). Shares have added about 10.2% in that time frame, outperforming the S&P 500. Will the recent positive tr...
Here Are Wednesday’s Top Wall Street Analyst Research Calls: DHL Group, NetApp, Nutanix, Oracle, Snowflake, Urban Outfitters, Zscaler and More
Bet_Noire / iStock via Getty Images Quick Read After a mixed start on Tuesday, all the major indices closed higher as hopes for a December rate cut rose. With the market holiday on Thursday and an e...
Kymera Trades Near 52-Week High: Time to Buy, Sell or Hold the Stock?
Shares of Kymera Therapeutics, Inc. KYMR touched a 52-week high of $68.8 on Nov. 24. The stock is currently trading at $66.04. The rally is most likely due to investor optimism around Kymera’s lead...
Kymera Therapeutics (KYMR): Exploring Valuation Following Recent Share Price Momentum
Kymera Therapeutics (KYMR) has quietly delivered a 12% gain over the past month, driven by steady investor interest. Although there is no single news event behind the move, the company's performance s...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
